Variant report

Variant	esv3393084
Chromosome Location	chr11:48000076-48004474
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:497)
CpG islands
(count:550)
Chromatin interactive
region (count:7)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:497 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr11:48001120-48001869	H1-hESC	embryonic stem cell:	n/a	n/a
2	BHLHE40	chr11:48002877-48002924	GM12878	blood:	n/a	n/a
3	BHLHE40	chr11:48002001-48002473	K562	blood:	n/a	chr11:48002237-48002253 chr11:48002138-48002154 chr11:48002104-48002120 chr11:48002375-48002391 chr11:48002146-48002162 chr11:48002240-48002256
4	BHLHE40	chr11:48002688-48003004	K562	blood:	n/a	n/a
5	BHLHE40	chr11:48003311-48003830	GM12878	blood:	n/a	n/a
6	BHLHE40	chr11:48000908-48001210	K562	blood:	n/a	n/a
7	BHLHE40	chr11:48002116-48002526	GM12878	blood:	n/a	chr11:48002237-48002253 chr11:48002138-48002154 chr11:48002375-48002391 chr11:48002146-48002162 chr11:48002240-48002256
8	BHLHE40	chr11:48003267-48003524	K562	blood:	n/a	n/a
9	CCNT2	chr11:48001687-48003494	K562	blood:	n/a	chr11:48002660-48002669 chr11:48002062-48002071 chr11:48003223-48003232
10	CEBPB	chr11:48002055-48002351	Hela-S3	cervix:	n/a	n/a
11	CEBPB	chr11:48004185-48004576	Hela-S3	cervix:	n/a	chr11:48004464-48004477
12	CEBPB	chr11:48002707-48003360	Hela-S3	cervix:	n/a	n/a
13	CEBPB	chr11:48003725-48003781	K562	blood:	n/a	n/a
14	CHD1	chr11:48002971-48003019	H1-hESC	embryonic stem cell:	n/a	n/a
15	CHD1	chr11:48002670-48003635	IMR90	lung:	n/a	n/a
16	CHD1	chr11:48002367-48002442	GM12878	blood:	n/a	n/a
17	CHD1	chr11:48002832-48002961	GM12878	blood:	n/a	n/a
18	CHD2	chr11:48001553-48003496	Hela-S3	cervix:	n/a	chr11:48001912-48001922
19	CHD2	chr11:48002116-48002201	K562	blood:	n/a	n/a
20	CHD2	chr11:48000967-48001044	HepG2	liver:	n/a	n/a
21	CREB1	chr11:48001883-48002477	A549	lung:	n/a	n/a
22	CTBP2	chr11:48000968-48001868	H1-hESC	embryonic stem cell:	n/a	n/a
23	CTCF	chr11:48001797-48001851	LNCaP	prostate:	n/a	n/a
24	CTCF	chr11:48002840-48002990	HRE	kidney:	n/a	n/a
25	CTCF	chr11:48002817-48002925	SK-N-SH_RA	brain:	n/a	n/a
26	CTCF	chr11:48001754-48001892	MCF-7	breast:	n/a	n/a
27	CTCF	chr11:48000986-48001129	MCF-7	breast:	n/a	n/a
28	CTCF	chr11:48002857-48002977	GM19238	blood:	n/a	n/a
29	CTCF	chr11:48001040-48001190	HBMEC	blood vessel:	n/a	n/a
30	CTCF	chr11:48002800-48002950	AG04449	skin:	n/a	n/a
31	CTCF	chr11:48002800-48002950	HMF	breast:	n/a	n/a
32	CTCF	chr11:48002840-48002990	GM12878	blood:	n/a	n/a
33	CTCF	chr11:48002840-48002990	GM12864	blood:	n/a	n/a
34	CTCF	chr11:48002820-48002970	SK-N-SH_RA	brain:	n/a	n/a
35	CTCF	chr11:48001749-48001862	MCF-7	breast:	n/a	n/a
36	CTCF	chr11:48002860-48003010	WERI-Rb-1	eye:	n/a	chr11:48002992-48003005
37	CTCF	chr11:48002991-48002995	H1-hESC	embryonic stem cell:	n/a	n/a
38	CTCF	chr11:48000972-48001109	H1-hESC	embryonic stem cell:	n/a	n/a
39	CTCF	chr11:48001680-48001830	AG09319	gingival:	n/a	n/a
40	CTCF	chr11:48002820-48002970	HPAF	blood vessel:	n/a	n/a
41	CTCF	chr11:48002840-48002990	K562	blood:	n/a	n/a
42	CTCF	chr11:48002780-48002930	GM12869	blood:	n/a	n/a
43	CTCF	chr11:48003001-48003005	GM19239	blood:	n/a	n/a
44	CTCF	chr11:48002820-48002970	GM12870	blood:	n/a	n/a
45	CTCF	chr11:48002840-48002990	HBMEC	blood vessel:	n/a	n/a
46	CTCF	chr11:48002894-48002937	MCF-7	breast:	n/a	n/a
47	CTCF	chr11:48000960-48001110	HepG2	liver:	n/a	n/a
48	CTCF	chr11:48000981-48001126	MCF-7	breast:	n/a	n/a
49	CTCF	chr11:48001126-48001127	K562	blood:	n/a	n/a
50	CTCF	chr11:48000999-48001105	GM12892	blood:	n/a	n/a

(count:550 , 50 per page) page: 1 2 3 4 5 6 7 ... 11

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr11:48003065-48003115	GM12892	blood:	n/a
2	chr11:48003065-48003115	GM12892	blood:	n/a
3	chr11:48001835-48001885	HPAEpiC	pulmonary alveolar:	n/a
4	chr11:48000611-48000661	BJ	skin:	n/a
5	chr11:48001835-48001885	A549	lung:	n/a
6	chr11:48001954-48002004	AG09319	gingival:	n/a
7	chr11:48001954-48002004	RPTEC	kidney:	n/a
8	chr11:48002566-48002616	U87	brain:	n/a
9	chr11:48000611-48000661	AG10803	skin:	n/a
10	chr11:48001954-48002004	ProgFib	skin:	n/a
11	chr11:48003169-48003219	SK-N-SH_RA	brain:	n/a
12	chr11:48001761-48001811	PANC-1	pancreas:	n/a
13	chr11:48002566-48002616	ProgFib	skin:	n/a
14	chr11:48002566-48002616	HCM	heart:	n/a
15	chr11:48000611-48000661	SKMC	muscle:	n/a
16	chr11:48001940-48001990	HCM	heart:	n/a
17	chr11:48003065-48003115	NHBE	bronchial:	n/a
18	chr11:48001835-48001885	GM12891	blood:	n/a
19	chr11:48001954-48002004	HRCEpiC	kidney:	n/a
20	chr11:48001669-48001719	PrEC	prostate:	n/a
21	chr11:48002566-48002616	Hepatocyte	liver:	n/a
22	chr11:48003065-48003115	AG09309	skin:	n/a
23	chr11:48003065-48003115	HPAEpiC	pulmonary alveolar:	n/a
24	chr11:48001669-48001719	AoSMC	blood vessel:	n/a
25	chr11:48002566-48002616	NHBE	bronchial:	n/a
26	chr11:48002566-48002616	SK-N-MC	brain:	n/a
27	chr11:48000611-48000661	HRPEpiC	eye:	n/a
28	chr11:48002566-48002616	LNCaP	prostate:	n/a
29	chr11:48002566-48002616	AG10803	skin:	n/a
30	chr11:48001669-48001719	SK-N-SH_RA	brain:	n/a
31	chr11:48001669-48001719	T-47D	breast:	n/a
32	chr11:48001669-48001719	U87	brain:	n/a
33	chr11:48002566-48002616	BJ	skin:	n/a
34	chr11:48001940-48001990	AG04450	lung:	fetal
35	chr11:48003065-48003115	HEK293	kidney:	embryo
36	chr11:48001835-48001885	MCF-7	breast:	n/a
37	chr11:48001940-48001990	HCPEpiC	choroid plexus:	n/a
38	chr11:48001954-48002004	HepG2	liver:	n/a
39	chr11:48003169-48003219	HPAEpiC	pulmonary alveolar:	n/a
40	chr11:48001761-48001811	GM12878	blood:	n/a
41	chr11:48001835-48001885	HL-60	blood:	n/a
42	chr11:48001761-48001811	GM12892	blood:	n/a
43	chr11:48001835-48001885	HEEpiC	esophagus:	n/a
44	chr11:48001835-48001885	HCM	heart:	n/a
45	chr11:48003169-48003219	T-47D	breast:	n/a
46	chr11:48001669-48001719	HIPEpiC	eye:	n/a
47	chr11:48001835-48001885	NHDF-neo	bronchial:	n/a
48	chr11:48003065-48003115	NT2-D1	testis:	n/a
49	chr11:48001835-48001885	NB4	blood:	n/a
50	chr11:48002566-48002616	CMK	blood:	n/a

(count:7 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr11:47998626..48001544-chr11:48011540..48013257,2	MCF-7	breast:
2	chr11:48003107..48006285-chr11:48013442..48016525,3	MCF-7	breast:
3	chr11:48000640..48001500-chr11:48131020..48132149,3	MCF-7	breast:
4	chr11:48001622..48003248-chr11:48003667..48005492,2	MCF-7	breast:
5	chr11:48002635..48003533-chr11:48130431..48131591,3	MCF-7	breast:
6	chr11:47955684..47956212-chr11:48000981..48001494,2	MCF-7	breast:
7	chr11:48002531..48005255-chr11:48006333..48009338,3	K562	blood:

No data

Variant related genes	Relation type
PTPRJ	TF binding region
PTPRJ	CpG island
ENSG00000149177	chromatin interactions

Extended variants
information (count: 110 )
Associated
traits (count: 62 )

Variant overlapped rSNPs/rCNVs (count:110 , 50 per page) page: 1 2 3

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs547922607	chr11:48000117-48000118	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs1976065	chr11:48000139-48000140	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs568365047	chr11:48000243-48000244	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs536499342	chr11:48000244-48000245	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs369669112	chr11:48000277-48000278	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs7124212	chr11:48000290-48000291	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs374099186	chr11:48000293-48000294	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs550197727	chr11:48000332-48000333	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs12283076	chr11:48000369-48000370	Weak transcription Enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs539673065	chr11:48000370-48000371	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs556611493	chr11:48000446-48000447	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs570096830	chr11:48000469-48000470	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs535795758	chr11:48000545-48000546	Weak transcription Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs900696	chr11:48000643-48000644	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
15	rs183645200	chr11:48000644-48000645	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
16	rs187787766	chr11:48000648-48000649	Weak transcription Bivalent Enhancer Enhancers	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
17	rs192660220	chr11:48000700-48000701	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs183611649	chr11:48000738-48000739	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs79837139	chr11:48000780-48000781	Weak transcription Bivalent Enhancer Enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs562596882	chr11:48000808-48000809	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
21	rs531307771	chr11:48000810-48000811	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
22	rs149093575	chr11:48000815-48000816	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
23	rs186773736	chr11:48000819-48000820	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
24	rs115837357	chr11:48000838-48000839	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
25	rs192583974	chr11:48000884-48000885	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs564474884	chr11:48000907-48000908	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs533570152	chr11:48000928-48000929	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs550112317	chr11:48000948-48000949	Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs558657111	chr11:48001029-48001030	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs151233291	chr11:48001082-48001083	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs535593904	chr11:48001087-48001088	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs140417440	chr11:48001120-48001121	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs566060722	chr11:48001136-48001137	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs184974212	chr11:48001157-48001158	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs554097054	chr11:48001177-48001178	Active TSS Enhancers Bivalent Enhancer Weak transcription Flanking Bivalent TSS/Enh Bivalent/Poised TSS Flanking Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs577253394	chr11:48001238-48001239	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs539572285	chr11:48001259-48001260	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs533719733	chr11:48001298-48001299	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs576224329	chr11:48001299-48001300	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs556092462	chr11:48001314-48001315	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs145527360	chr11:48001325-48001326	Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs189808650	chr11:48001417-48001418	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs541581118	chr11:48001458-48001459	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs73462867	chr11:48001471-48001472	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
45	rs571691790	chr11:48001475-48001476	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs540672362	chr11:48001492-48001493	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs111293538	chr11:48001530-48001531	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs564392247	chr11:48001543-48001544	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs370616015	chr11:48001599-48001600	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Enhancers Flanking Active TSS Weak transcription Bivalent Enhancer Genic enhancers	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs77587162	chr11:48001602-48001603	Bivalent/Poised TSS Active TSS Flanking Bivalent TSS/Enh Flanking Active TSS Enhancers Transcr. at gene 5' and 3' Weak transcription	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:62)

Disease	PMID	Source
Parathyroid adenoma	22454399	CNVD
Medulloblastoma	21979893	CNVD
Chordoma	21602918	CNVD
Breast cancer	21949216	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	19222835	CNVD
T-cell acute lymphoblastic leukemia	20065082	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Beckwith-Wiedemann syndrome	21518781	CNVD
Wilms tumour	21518781	CNVD
Hepatoblastoma	21518781	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Gastrointestinal stromal cancer	17535989	CNVD
Paraganglioma	17535989	CNVD
Pulmonary chondroma	17535989	CNVD
Wilms tumour	21544195	CNVD
Gastric cancer	17908304	CNVD
Multiple myeloma	20724749	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Non-small cell lung cancer	21385341	CNVD
Intellectual disability	22102821	CNVD
Renal cell carcinoma	18194544	CNVD
Breast cancer	17603634	CNVD
Chordoma	18071362	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Potocki-Shaffer syndrome	19222835	CNVD
WAGR syndrome	19222835	CNVD
small cell lung cancer	20016488	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Myelofibrosis	22110671	CNVD
Melanoma	18172304	CNVD
Intracranial ependymoma	16609018	CNVD
Myxofibrosarcoma	16751306	CNVD
Potocki-Shaffer syndrome	22470819	CNVD
Neurodevelopmental disorder	22521361	CNVD
Breast cancer	16608533	CNVD
Hirschsprung''s Disease	21712996	CNVD
Follicular lymphoma	20505157	CNVD
Colorectal cancer	21128281	CNVD
Breast cancer	20409316	CNVD
Neurocytoma	17123091	CNVD
Central neurocytomas	17123091	CNVD
Multiple myeloma	16616336	CNVD
Cancer	17160897	CNVD
Mantle cell lymphoma	19029149	CNVD
Glioblastoma multiforme	21138945	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21364760	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	22581003	CNVD
Glioblastoma multiforme	21390271	CNVD
Acute lymphoblastic leukemia	20699438	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	21990379	CNVD

Chromatin state (count:653 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr11:47993400-48001400	Weak transcription	Right Atrium	heart
2	chr11:47995800-48000800	Weak transcription	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
3	chr11:47996000-48000400	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
4	chr11:47996200-48000600	Weak transcription	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
5	chr11:47996200-48000800	Weak transcription	Brain Substantia Nigra	brain
6	chr11:47996400-48001000	Weak transcription	Primary T cells fromperipheralblood	blood
7	chr11:47996400-48001200	Weak transcription	Brain Hippocampus Middle	brain
8	chr11:47996400-48001400	Enhancers	Primary neutrophils fromperipheralblood	blood
9	chr11:47996400-48001400	Weak transcription	Stomach Mucosa	stomach
10	chr11:47996400-48001600	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
11	chr11:47996400-48001600	Weak transcription	Fetal Lung	lung
12	chr11:47996600-48000800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
13	chr11:47996600-48000800	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
14	chr11:47996600-48000800	Weak transcription	HUES48 Cell Line	embryonic stem cell
15	chr11:47996600-48000800	Weak transcription	HUES64 Cell Line	embryonic stem cell
16	chr11:47996600-48001200	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
17	chr11:47996600-48001200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
18	chr11:47996600-48001200	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
19	chr11:47996600-48001200	Weak transcription	Fetal Kidney	kidney
20	chr11:47996600-48001400	Weak transcription	Adipose Nuclei	Adipose
21	chr11:47996600-48001400	Weak transcription	Skeletal Muscle Male	skeletal muscle
22	chr11:47996600-48001400	Weak transcription	GM12878-XiMat	blood
23	chr11:47996600-48001400	Weak transcription	NHLF	lung
24	chr11:47996600-48001600	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
25	chr11:47996800-48001000	Weak transcription	NHDF-Ad	bronchial
26	chr11:47996800-48001200	Weak transcription	NH-A	brain
27	chr11:47996800-48001400	Weak transcription	HSMM	muscle
28	chr11:47996800-48001600	Weak transcription	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
29	chr11:47996800-48001600	Weak transcription	Muscle Satellite Cultured Cells	--
30	chr11:47996800-48001600	Weak transcription	Osteobl	bone
31	chr11:47997000-48000600	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
32	chr11:47997000-48001600	Weak transcription	H9 Derived Neuron Cultured Cells	ES cell derived
33	chr11:47997000-48001600	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
34	chr11:47997200-48000400	Weak transcription	Primary B cells from cord blood	blood
35	chr11:47997200-48001000	Weak transcription	Skeletal Muscle Female	skeletal muscle
36	chr11:47997200-48001200	Weak transcription	Cortex derived primary cultured neurospheres	brain
37	chr11:47997400-48000400	Weak transcription	H9 Derived Neuronal Progenitor Cultured Cells	ES cell derived
38	chr11:47997400-48000400	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
39	chr11:47997400-48000400	Weak transcription	Primary B cells from peripheral blood	blood
40	chr11:47997400-48000800	Weak transcription	ES-UCSF4 Cell Line	embryonic stem cell
41	chr11:47997400-48001600	Weak transcription	Lung	lung
42	chr11:47997800-48001200	Weak transcription	Placenta	Placenta
43	chr11:47998200-48000200	Enhancers	A549	lung
44	chr11:47999000-48000400	Enhancers	Liver	Liver
45	chr11:47999600-48000600	Weak transcription	Hela-S3	cervix
46	chr11:47999600-48000800	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr11:47999600-48001400	Weak transcription	IMR90 fetal lung fibroblasts Cell Line	lung
48	chr11:47999600-48001600	Weak transcription	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
49	chr11:48000000-48000800	Enhancers	HepG2	liver
50	chr11:48000200-48000600	Weak transcription	A549	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links